Remote video URL
Your peers have not rated this talk yet.
5-minute watch | Talk 2 of 2

EU CAR T: Access and reimbursement to CAR T-cell therapy

How can we address reimbursement challenges for CAR T?

Adam Hutchings
Dolon, UK

Adam Hutchings of Dolon, UK, discusses access to CAR T therapies including current challenges and future solutions

Read more

Talks in this series

4-minute watch | Talk 1 of 2
EU CAR T: Access and reimbursement to CAR T-cell therapy
4-minute watch
EU CAR T: Access and reimbursement to CAR T-cell therapy

Why is timely reimbursement of CAR T important for our patients?

4-minute watch | Talk 1 of 2
EU CAR T: Access and reimbursement to CAR T-cell therapy
4-minute watch
EU CAR T: Access and reimbursement to CAR T-cell therapy

Why is timely reimbursement of CAR T important for our patients?

Interested in this topic?